21st Annual NATA Symposium Scientific Programme

Choose your Timezone (Toggle Map):
Day 1
12 Apr 2021
Day 2
13 Apr 2021
Day 3
14 Apr 2021
Day 4
15 Apr 2021
Day 5
16 Apr 2021

09:00 - 10:00 CEST

SESSION 1A

SAFETY OF BLOOD AND BLOOD PRODUCTS

Chairs: TBD

09:00 - 09:15 CEST

Transfusion-related immunomodulation – theoretical or clinically relevant?

David Baron, Vienna, Austria

09:15 - 09:30 CEST

Pathogen testing in 2021 – what is necessary?

Maria Beatrice Rondinelli, Rome, Italy

09:30 - 09:45 CEST

Age of blood – problem solved or ongoing debate?

Philip C. Spinella, St. Louis, MO, USA

09:45 - 10:00 CEST

Discussion

11:30 - 12:30 CEST

SESSION 2A

HOT TOPICS I – CLINICAL TRANSFUSION PRACTICE

Chairs: TBD

11:30 - 11:45 CEST

How to approach liberal vs. restrictive transfusion

Anders Møller, Slagelse, Denmark

11:45 - 12:00 CEST

Transfusion strategy in myocardial infarction – REALITY trial

Philippe Gabriel Steg, Paris, France

12:00 - 12:15 CEST

Whole blood – now or never?

Jakob Stensballe, Copenhagen, Denmark

12:15 - 12:30 CEST

Discussion

17:00 - 18:00 CEST

SESSION 3A

PATIENT BLOOD MANAGEMENT – WHAT I HAVE TO KNOW AS A TRAINEE

Chairs: TBD

17:00 - 17:15 CEST

The basics of PBM – pillar 1

Ane Abad Motos, Madrid, Spain

17:15 - 17:30 CEST

The basics of PBM – pillar 2

Dania Fischer, Frankfurt, Germany

17:30 - 17:45 CEST

The basics of PBM – pillar 3

Tina Tomić Mahečić, Zagreb, Croatia

17:45 - 18:00 CEST

Discussion

19:30 - 20:30 CEST

SESSION 4A

HOT TOPICS II – PBM RESEARCH AND IMPLEMENTATION

Chairs: TBD

19:30 - 19:45 CEST

Top 5 most important PBM publications in 2020–2021

David Faraoni, Toronto, ON, Canada

19:45 - 20:00 CEST

RCTs in PBM – do they give us all the answers?

Axel Hofmann, Zurich, Switzerland

20:00 - 20:15 CEST

Maturity Assessment in PBM – monitoring implementation at the national level

Elvira Bisbe, Barcelona, Spain

20:15 - 20:30 CEST

Discussion

09:00 - 10:00 CEST

SESSION 3A

PATIENT BLOOD MANAGEMENT – WHAT I HAVE TO KNOW AS A TRAINEE

Chairs: TBD

09:00 - 09:15 CEST

The basics of PBM – pillar 1

Ane Abad Motos, Madrid, Spain

09:15 - 09:30 CEST

The basics of PBM – pillar 2

Dania Fischer, Frankfurt, Germany

09:30 - 09:45 CEST

The basics of PBM – pillar 3

Tina Tomić Mahečić, Zagreb, Croatia

09:45 - 10:00 CEST

Discussion

11:30 - 12:30 CEST

SESSION 4B

HOT TOPICS II – PBM RESEARCH AND IMPLEMENTATION

Chairs: TBD

11:30 - 11:45 CEST

Top 5 most important PBM publications in 2020–2021

David Faraoni, Toronto, ON, Canada

11:45 - 12:00 CEST

RCTs in PBM – do they give us all the answers?

Axel Hofmann, Zurich, Switzerland

12:00 - 12:15 CEST

Maturity Assessment in PBM – monitoring implementation at the national level

Elvira Bisbe, Barcelona, Spain

12:15 - 12:30 CEST

Discussion

17:00 - 18:00 CEST

SESSION 1B

SAFETY OF BLOOD AND BLOOD PRODUCTS

Chairs: TBD

17:00 - 17:15 CEST

Transfusion-related immunomodulation – theoretical or clinically relevant?

David Baron, Vienna, Austria

17:15 - 17:30 CEST

Pathogen testing in 2021 – what is necessary?

Maria Beatrice Rondinelli, Rome, Italy

17:30 - 17:45 CEST

Age of blood – problem solved or ongoing debate?

Philip C. Spinella, St. Louis, MO, USA

17:45 - 18:00 CEST

Discussion

19:30 - 20:30 CEST

SESSION 2B

HOT TOPICS I – CLINICAL TRANSFUSION PRACTICE

Chairs: TBD

19:30 - 19:45 CEST

How to approach liberal vs. restrictive transfusion

Anders Møller, Slagelse, Denmark

19:45 - 20:00 CEST

Transfusion strategy in myocardial infarction – REALITY trial

Philippe Gabriel Steg, Paris, France

20:00 - 20:15 CEST

Whole blood – now or never?

Jakob Stensballe, Copenhagen, Denmark

20:15 - 20:30 CEST

Discussion

09:00 - 10:00 CEST

SESSION 5A

CELL SALVAGE – OUTDATED OR UP TO DATE?

Chairs: TBD

09:00 - 09:15 CEST

Cell salvage in paediatrics

Susan M. Goobie, Boston, MA, USA

09:15 - 09:30 CEST

Cell salvage in the bleeding trauma patient

Lidia Mora Miquel, Barcelona, Spain

09:30 - 09:45 CEST

Cell salvage in cancer surgery – a no go?

Timo Seyfried, Regensburg, Germany

09:45 - 10:00 CEST

Discussion

11:30 - 12:30 CEST

SESSION 6A

HOT TOPICS III – PERIOPERATIVE ANAEMIA AND IRON DEFICIENCY

Chairs: TBD

11:30 - 11:45 CEST

The anaemia clinic – a must for every hospital

Elvira Bisbe, Barcelona, Spain

11:45 - 12:00 CEST

Preoperative IV iron in major abdominal surgery: PREVENTT trial

Toby Richards, Perth, WA, Australia

12:00 - 12:15 CEST

EPO – a new kid on the block?

Sigismond Lasocki, Angers, France

12:15 - 12:30 CEST

Discussion

17:00 - 18:00 CEST

SESSION 7A

PATIENT BLOOD MANAGEMENT – A POLITICAL ISSUE?

Chairs: TBD

17:00 - 17:15 CEST

WHO Action framework for blood products – focus on PBM

Yuyun Maryuningsih, Geneva, Switzerland

17:15 - 17:30 CEST

Role of the European Union in promoting PBM

TBD

17:30 - 17:45 CEST

PBM – a spectre for blood bankers?

TBD

17:45 - 18:00 CEST

Discussion

19:30 - 20:30 CEST

SESSION 8

SABM SESSION – A PRACTICAL APPROACH TO PATIENT BLOOD MANAGEMENT

Chairs: TBD

19:30 - 19:45 CEST

The role of the surgeon in PBM

Pierre Tibi, Prescott, AZ, USA

19:45 - 20:00 CEST

The role of a PBM coordinator

Sherri Ozawa, Englewood, NJ, USA

20:00 - 20:15 CEST

Wind of change – how to initiate PBM in real life?

Aryeh Shander, Englewood, NJ, USA

20:15 - 20:30 CEST

Wind of change – how to initiate PBM in real life?

Discussion

09:00 - 10:30 CEST

SESSION 7B

PATIENT BLOOD MANAGEMENT – A POLITICAL ISSUE?

Chairs: TBD

09:00 - 09:15 CEST

WHO Action framework for blood products – focus on PBM

Yuyun Maryuningsih, Geneva, Switzerland

09:15 - 09:30 CEST

Role of the European Union in promoting PBM

TBD

09:30 - 09:45 CEST

PBM – a spectre for blood bankers?

TBD

09:45 - 10:00 CEST

Discussion

11:30 - 12:30 CEST

SESSION 9

ASPBM SESSION

Chairs: TBD

11:30 - 11:45 CEST

TBD

TBD

11:45 - 12:00 CEST

TBD

TBD

12:00 - 12:15 CEST

TBD

TBD

12:15 - 12:30 CEST

Discussion

17:00 - 18:00 CEST

SESSION 10A

PATIENT BLOOD MANAGEMENT IN THE ICU

Chairs: TBD

17:00 - 17:15 CEST

Role of iron and EPO in the ICU

Sigismond Lasocki, Angers, France

17:15 - 17:30 CEST

Coagulopathies in the ICU

Isabell Pekrul, Munich, Germany

17:30 - 17:45 CEST

Transfusion triggers for critically ill patients – ESICM guidelines

Alexander P. J. Vlaar, Amsterdam, The Netherlands

17:45 - 18:00 CEST

Discussion

19:30 - 20:30 CEST

SESSION 11A

HOT TOPICS IV – BLEEDING AND THROMBOSIS

Chairs: TBD

19:30 - 19:45 CEST

When to use tranexamic acid?

Beverley J. Hunt, London, UK

19:45 - 20:00 CEST

Point-of-care coagulation monitoring – the way to go

Jakob Stensballe, Copenhagen, Denmark

20:00 - 20:15 CEST

COVID-19, haemostasis and thrombosis

Charles-Marc Samama, Paris, France

20:15 - 20:30 CEST

Discussion

09:00 - 10:30 CEST

SESSION 7B

PATIENT BLOOD MANAGEMENT – A POLITICAL ISSUE?

Chairs: TBD

09:00 - 09:15 CEST

WHO Action framework for blood products – focus on PBM

Yuyun Maryuningsih, Geneva, Switzerland

09:15 - 09:30 CEST

Role of the European Union in promoting PBM

TBD

09:30 - 09:45 CEST

PBM – a spectre for blood bankers?

TBD

09:45 - 10:00 CEST

Discussion

11:30 - 12:30 CEST

SESSION 9

ASPBM SESSION

Chairs: TBD

11:30 - 11:45 CEST

TBD

TBD

11:45 - 12:00 CEST

TBD

TBD

12:00 - 12:15 CEST

TBD

TBD

12:15 - 12:30 CEST

Discussion

17:00 - 18:00 CEST

SESSION 10A

PATIENT BLOOD MANAGEMENT IN THE ICU

Chairs: TBD

17:00 - 17:15 CEST

Role of iron and EPO in the ICU

Sigismond Lasocki, Angers, France

17:15 - 17:30 CEST

Coagulopathies in the ICU

Isabell Pekrul, Munich, Germany

17:30 - 17:45 CEST

Transfusion triggers for critically ill patients – ESICM guidelines

Alexander P. J. Vlaar, Amsterdam, The Netherlands

17:45 - 18:00 CEST

Discussion

19:30 - 20:30 CEST

SESSION 11A

HOT TOPICS IV – BLEEDING AND THROMBOSIS

Chairs: TBD

19:30 - 19:45 CEST

When to use tranexamic acid?

Beverley J. Hunt, London, UK

19:45 - 20:00 CEST

Point-of-care coagulation monitoring – the way to go

Jakob Stensballe, Copenhagen, Denmark

20:00 - 20:15 CEST

COVID-19, haemostasis and thrombosis

Charles-Marc Samama, Paris, France

20:15 - 20:30 CEST

Discussion

* CEST, Central European Summer Time (UTC +2)